Oncology
Oncology
successful oncology formulation marketing requires a comprehensive approach that integrates scientific expertise, market insights, and a patient-cantered focus to effectively bring innovative cancer treatments to market and improve outcomes for cancer patients.
Creating a comprehensive product portfolio in the field of oncology requires a diverse range of products to address various types and stages of cancer and Medicines are often used in combination or as part of a multidisciplinary approach to provide comprehensive care for cancer patients. Additionally, each patient's treatment plan is peers.
PRODUCTS PORTFOLIO
Tablets
- Anastrozole Tablets 1mg
- Abiraterone Acetate Tablets 250 mg and 500 mg
- Axitinib Tablets 1 mg and 5 mg
- Busulfan Tablets 2mg
- Bicalutamide Tablets 150 mg
- Chlorambucil Tablets 2 mf and 5 mg
- Capecitabine Tablets 500 mg
- Dasatinib Tablets 20mg, 50 mg, 70 mg and 100 mg
- Erlotinib Tablets 100 mg and 150 mg
- Gefitinib Tablets 250 mg
- Imatinib Mesylate Tablets 100 mg and 400 mg
- Letrozole Tablets 2.5 mg
- Lapatinib Tablets 250 mg
- Methotrexate Tablets 2.5 mg
- Melphalan Tablets 2mg and 5 mg
- Mitotane Tablets 500 mg
- Mercaptopurine Tablets 50 mg
- Pazopanib Tablets 200 mg and 400 mg
- Sorafenib Tablets 200 mg
- Tamoxifen Tablets 10 mg, 20 mg and 40 mg
Capsules
- Temozolomide Capsules 20 mg, 100 mg and 250 mg
- Lenalidomide Capsules 10 mg and 25 mg
- Lomustine Capsules 40 mg
- Nilotinib Capsules 100 mg and 150 mg
- Sunitinib Capsules 12.5 mg, 25 mg and 50 mg
- Thalidomide Capsules 50 mg and 100 mg
- Hydroxyurea Capsules 500 mg
Injectables
- Amifostine for injection 500 mg
- Azacitidine for Injection 100 mg
- Alb. paclitaxel for injection 100 mg
- Carmustine for Injection 100 mg
- Iphosphamide for Injection 100 mg
- Melphalan for Injection 50 mg
- Thiotepa for Injection 100 mg